Literature DB >> 17179715

Thrombosis of internal carotid artery after cisplatin-based chemotherapy.

Janja Pretnar-Oblak, Majda Zaletel, Monika Jagodic, Marjan Zaletel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17179715     DOI: 10.1159/000098062

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


× No keyword cloud information.
  6 in total

1.  High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis.

Authors:  Russell A Moore; Nelly Adel; Elyn Riedel; Manisha Bhutani; Darren R Feldman; Nour Elise Tabbara; Gerald Soff; Rekha Parameswaran; Hani Hassoun
Journal:  J Clin Oncol       Date:  2011-08-01       Impact factor: 44.544

2.  Acute Left Internal Carotid Artery and Right Popliteal Artery Occlusion Related to Cisplatin-Gemcitabine Based Chemotherapy.

Authors:  Saman Zafar; Rashmika Potdar; Andrew Tiu; Gabor Varadi; John Leighton
Journal:  Case Rep Neurol Med       Date:  2018-12-17

3.  Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy - a cohort study.

Authors:  Muhammad Nauman Zahir; Quratulain Shaikh; Munira Shabbir-Moosajee; Adnan Abdul Jabbar
Journal:  BMC Cancer       Date:  2017-01-16       Impact factor: 4.430

4.  Characterization of Cardiovascular Alterations Induced by Different Chronic Cisplatin Treatments.

Authors:  Esperanza Herradón; Cristina González; José A Uranga; Raquel Abalo; Ma I Martín; Visitacion López-Miranda
Journal:  Front Pharmacol       Date:  2017-05-08       Impact factor: 5.810

5.  Extensive arterial and venous thrombo-embolism with chemotherapy for testicular cancer: a case report.

Authors:  Ramesh Batra; Jonathan N Davies; Duncan Wheatley
Journal:  Cases J       Date:  2009-11-24

Review 6.  Vascular toxic effects of cancer therapies.

Authors:  Joerg Herrmann
Journal:  Nat Rev Cardiol       Date:  2020-03-26       Impact factor: 32.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.